GFAP and brain ischemia: The expression of Gfap, an established marker of astrocyte activation in brain ischemia, also increased significantly, further suggesting that the developed model was reproducible and comparable to already-established changes in ischemia, providing suitable substrate to explore the effects of rTMS.